We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Copaxone Approval Boosts Teva Amid Patent Struggles
FDA Copaxone Approval Boosts Teva Amid Patent Struggles
After a tough 2013, Teva received good news Jan. 29 as the FDA approved a new formulation of its blockbuster drug Copaxone, helping the product gain new market share as Teva fervently fights off generic competition.